Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis.

[1]  Jennifer K. Sun,et al.  A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes , 2019, Nature Medicine.

[2]  M. Nishida,et al.  Mitochondrial dynamics in exercise physiology , 2019, Pflügers Archiv - European Journal of Physiology.

[3]  A. Scheen,et al.  Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease. , 2018, Diabetes & metabolism.

[4]  Christopher D. Brown,et al.  Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease , 2018, Nature Medicine.

[5]  Haojia Wu,et al.  Single-Cell Transcriptomics of a Human Kidney Allograft Biopsy Specimen Defines a Diverse Inflammatory Response. , 2018, Journal of the American Society of Nephrology : JASN.

[6]  G. Turcatti,et al.  Targeting STING with covalent small-molecule inhibitors , 2018, Nature.

[7]  G. Karaca,et al.  Interleukin-1β Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis. , 2018, Journal of the American Society of Nephrology : JASN.

[8]  G. Barish,et al.  Genomic integration of ERRγ-HNF1β regulates renal bioenergetics and prevents chronic kidney disease , 2018, Proceedings of the National Academy of Sciences.

[9]  H. Sugiyama,et al.  Estrogen-related receptor α is essential for maintaining mitochondrial integrity in cisplatin-induced acute kidney injury. , 2018, Biochemical and biophysical research communications.

[10]  Chengxiang Qiu,et al.  Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming , 2018, bioRxiv.

[11]  W. Lam,et al.  cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development. , 2018, Trends in immunology.

[12]  P. Heagerty,et al.  Diabetes and CKD in the United States Population, 2009-2014. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[13]  T. Yoo,et al.  PGC-1α Protects from Notch-Induced Kidney Fibrosis Development. , 2017, Journal of the American Society of Nephrology : JASN.

[14]  Zhengfan Jiang,et al.  NEMO–IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS–STING Pathway , 2017, The Journal of Immunology.

[15]  Neil R. Powe,et al.  Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy , 2017, The Lancet.

[16]  Chengxiang Qiu,et al.  Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits , 2017, EBioMedicine.

[17]  J. C. Ralston,et al.  Fatty Acids and NLRP3 Inflammasome-Mediated Inflammation in Metabolic Tissues. , 2017, Annual review of nutrition.

[18]  Frank Buttgereit,et al.  Metabolic regulation of inflammation , 2017, Nature Reviews Rheumatology.

[19]  B. Wang,et al.  Liver X receptor β increases aquaporin 2 protein level via a posttranscriptional mechanism in renal collecting ducts. , 2017, American journal of physiology. Renal physiology.

[20]  M. Afkarian,et al.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. , 2017, American journal of physiology. Renal physiology.

[21]  L. Gleeson,et al.  Metabolic reprogramming & inflammation: Fuelling the host response to pathogens. , 2016, Seminars in immunology.

[22]  Zhijian J. Chen,et al.  Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing , 2016, Nature Immunology.

[23]  Denise N. Bronner,et al.  Measurement of Mitochondrial DNA Release in Response to ER Stress. , 2016, Bio-protocol.

[24]  M. Breyer,et al.  The next generation of therapeutics for chronic kidney disease , 2016, Nature Reviews Drug Discovery.

[25]  A. House,et al.  Drug Disposition Issues in CKD: Implications for Drug Discovery and Regulatory Approval. , 2016, Advances in chronic kidney disease.

[26]  M. Bhasin,et al.  PGC1α-dependent NAD biosynthesis links oxidative metabolism to renal protection , 2016, Nature.

[27]  K. Reidy,et al.  Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism. , 2016, Journal of the American Society of Nephrology : JASN.

[28]  K. Suszták,et al.  Epithelial Plasticity versus EMT in Kidney Fibrosis. , 2016, Trends in molecular medicine.

[29]  Jun Wada,et al.  Innate immunity in diabetes and diabetic nephropathy , 2016, Nature Reviews Nephrology.

[30]  Denise N. Bronner,et al.  Endoplasmic Reticulum stress activates the inflammasome via NLRP 3-caspase-2 driven mitochondrial damage , 2015 .

[31]  J. Bonventre,et al.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD , 2015, Nature Reviews Nephrology.

[32]  R. Means,et al.  Mitochondrial DNA Stress Primes the Antiviral Innate Immune Response , 2014, Nature.

[33]  Kumar Sharma,et al.  Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development , 2014, Nature Medicine.

[34]  Katalin Susztak,et al.  Molecular mechanisms of diabetic kidney disease. , 2014, The Journal of clinical investigation.

[35]  J. Gustafsson,et al.  Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice , 2014, Proceedings of the National Academy of Sciences.

[36]  W. Cushman,et al.  Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease , 2013, Annals of Internal Medicine.

[37]  Matthew J. Rardin,et al.  Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. , 2012, Cell metabolism.

[38]  J. Kolesar,et al.  Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. , 2012, Biochimica et biophysica acta.

[39]  C. Moraes,et al.  Mitochondrial transcription: lessons from mouse models. , 2012, Biochimica et biophysica acta.

[40]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[41]  M. Bhasin,et al.  PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. , 2011, The Journal of clinical investigation.

[42]  K. Suszták,et al.  Transcriptome Analysis of Human Diabetic Kidney Disease , 2011, Diabetes.

[43]  U. Dobrindt,et al.  Pathogen Specific, IRF3-Dependent Signaling and Innate Resistance to Human Kidney Infection , 2010, PLoS pathogens.

[44]  R. Foley,et al.  Chronic kidney disease awareness, screening and prevention: Rationale for the design of a public education program , 2010, Nephrology.

[45]  R. Foley.  Temporal trends in the burden of chronic kidney disease in the United States , 2010, Current opinion in nephrology and hypertension.

[46]  Y. Guan,et al.  PPARs and the kidney in metabolic syndrome. , 2008, American journal of physiology. Renal physiology.

[47]  R. Scarpulla.  Transcriptional paradigms in mammalian mitochondrial biogenesis and function. , 2008, Physiological reviews.

[48]  F. Gonzalez,et al.  PPARα Protects Proximal Tubular Cells from Acute Fatty Acid Toxicity , 2007 .

[49]  M. Rudnicki,et al.  Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. , 2007, Kidney international.

[50]  A. Sugawara,et al.  Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. , 2006, Diabetes.

[51]  D. Kohan,et al.  Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Lingli Wang,et al.  A Transcriptional Profile of Aging in the Human Kidney , 2004, PLoS biology.

[53]  Y. Guan.  Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.

[54]  H. Li,et al.  Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Jens C. Brüning,et al.  Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression , 1999, Nature Genetics.

[56]  G. Barsh,et al.  Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice , 1998, Nature Genetics.

[57]  L. Mandel.  Metabolic substrates, cellular energy production, and the regulation of proximal tubular transport. , 1985, Annual review of physiology.